机译:纳迪亚大妇虫前列腺特异性抗原斜率是一种独立的预后标志物,用于鉴定男性在激进前列腺切除术后前列腺癌的临床复发风险降低
Division of Urologic Surgery Duke Cancer Institute Duke University Medical Center Box 3707 Duke;
Department of Laboratory Medicine Memorial Sloan-Kettering Cancer Center New York NY United;
Leroy T. Canoles Jr. Cancer Research Center Department of Pathology Eastern Virginia Medical;
Urology Eastern Virginia Medical School Norfolk VA United States;
Genitourinary Cancer Research Laboratory Department of Urology University of Washington Seattle;
Department of Laboratory Medicine Memorial Sloan-Kettering Cancer Center New York NY United;
Department of Surgery Memorial Sloan-Kettering Cancer Center New York NY United States;
Iris Molecular Diagnostics Carlsbad CA United States;
Iris Molecular Diagnostics Carlsbad CA United States;
Iris Molecular Diagnostics Carlsbad CA United States;
Iris Molecular Diagnostics Carlsbad CA United States;
Iris Molecular Diagnostics Carlsbad CA United States;
Iris Molecular Diagnostics Carlsbad CA United States;
机译:NADiA Prosvue前列腺特异性抗原斜率是一项独立的预后标志物,可用于识别根治性前列腺切除术后前列腺癌临床复发风险降低的男性
机译:纳迪亚大疗法前列腺特异性抗原坡,Capra-s和前列腺癌特异性生存后自由基前列腺切除术后
机译:纳迪亚大疗法前列腺特异性抗原坡,Capra-s和前列腺癌特异性生存在激进的前列腺切除术后编辑评论
机译:HIFU治疗外梁放射治疗后前列腺癌的局部复发和激进前列腺切除术 - 5.5年经验
机译:使用血清前列腺特异性抗原的倍增时间和变化,以确定自由基前列腺切除术后前列腺癌的继发性治疗
机译:Nadia®Prosvue™PSA斜率是一种独立的预后标志物用于识别男性在激进前列腺切除术后前列腺癌临床复发的风险降低
机译:NADiA ProsVue前列腺特异性抗原斜率是一项独立的预后标志物,可用于识别根治性前列腺切除术后前列腺癌临床复发风险降低的男性。